期刊文献+

甲钴胺治疗糖尿病周围神经病变120例临床观察

Diabetic Neuropathy Clinical Observation of 120 Cases Mecobalamin
原文传递
导出
摘要 目的:观察甲钴胺治疗糖尿病周围神经病变的临床疗效。方法:将120例患者在基础治疗的基础上随机分为治疗组(静脉注射甲钴胺治疗组)与对照组(予维生素B12100 mg肌注治疗及口服尼莫地平),观察患者的多伦多DNP临床积分及神经传导速度。结果:治疗组总有效率为97.14%,对照组为74.00%,治疗组改善神经传导速度均优于对照组( p<0.05)。结论:甲钴胺静脉注射可明显改善糖尿病下肢周围神经病变患者的症状,提高神经传导速度,且安全有效。 Objective:To observation the curative effect of mecobalamin injection on DPN .Methods:120 cases of DPN were randomly divided into the control group (n=56)and the treatment group(n=64);the control group was given foundation treatment and nimodipine tablets and Vitb12,the treatment group plus mecobalamin injection on the basis of the treatment of the control group ,All cases in two group were on treatment for 30 days,then analyzed the data of Toronto DNP clinical integral and nerve conduction velocity .Results:There was significant to improve the nerve conduction velocity and clinical symptoms for the patients in treatment group (P 〈0.05).Conclusion:mecobalamin injection can significantly improve the nerve conduction velocity and clinical symptoms quickly and safely for the DPN .
作者 李雪梅
出处 《中国伤残医学》 2014年第19期17-18,共2页 Chinese Journal of Trauma and Disability Medicine
关键词 糖尿病周围神经病变 甲钴胺 尼莫地平 神经传导速度 DPN Mecobalamin injection Nimodipine tablets Nerve conduction velocity
  • 相关文献

参考文献6

二级参考文献52

  • 1付艳芹,张东铭,辛雅萍,张苏河.α-硫辛酸对糖尿病周围神经病变的疗效及对氧化应激的影响[J].中国实用神经疾病杂志,2010,13(23):70-71. 被引量:18
  • 2贾伟平,沈琴,包玉倩,陆俊茜,李鸣,项坤三.糖尿病周围神经病变的检测方法及其诊断价值的评估[J].中华医学杂志,2006,86(38):2707-2710. 被引量:87
  • 3汤正义.糖尿病周围神经病变客观检查方法的应用和研究现状[J].内科理论与实践,2007,2(3):157-159. 被引量:12
  • 4Perkins B A, Bril V, Olaleye D, et al. Simple screening tests for peripheral neuropathy in the diabetes clinic [ J ]. Diabetes Care, 2001, 24(2):250-256.
  • 5Bril V, Perkins B A. Validation of the Toronto clinical scotinS system for diabetic polyneuropathy [ J ]. Diabetes Care, 2002, 25(11) :2048-2052.
  • 6Fabian W, Majkowska L, Stefanski A, et al. Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by the general practitioners [ J ]. Przegl Lek, 2005,62(4) :201-205.
  • 7Janghorbani M, Rezvanian H, Kachooei A, et al. Peripheral neuropathy in Type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk facwrs [ J ]. Acta Neurel Scand, 2006,114(6) :384-391.
  • 8Bouhon A J, Vinik A I, Arezzo J C, et al. A statement by the Amecican diabetes association: Diabetic neuropathies [J]. Diabetes Care, 2005, 28(4) :956-962.
  • 9Dyck P J, Davies J L, Wilson D M, et al. Risk factors for severity of diabetic polyneuropathy : intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort [J]. Diabetes Care, 1999,22(9) :1479-1486.
  • 10Brownlec M. The pathobiology of diabetic complications. A unifying mechanism [ J ]. Diabetes, 2005, 54 ( 6 ) : 1615-1625.

共引文献663

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部